A Resource for Healthcare and Social Services Professionals
June 15, 2023
3:00 pm–4:00 pm ET
This one-hour course will review current epidemiological trends related smoking and tobacco/nicotine use disorder among gender and sexuality diverse people.
Via Zoom
The series, Addressing SUD in Gender and Sexuality Diverse (GSD) Patients, aims to provide addiction treatment providers with evidence-based information about the best practices related to engaging, assessing, and devising treatment plans for patients who identify as gender or sexuality diverse. The 4-part series will explore topics of particular concern to the GSD community including alcohol use, tobacco use, club drug use, and culturally responsive care for gender expansive patients. Didactic learning will be supplemented with a question and answer period for participants to ask experts in the field about particular challenges or considerations in caring for the GSD population.
This one-hour course will review current epidemiological trends related smoking and tobacco/nicotine use disorder among gender and sexuality diverse people. Contributing factors to higher rates of combustible cigarette and electronic cigarette consumption will be reviewed through a minority stress framework. The course will review strategies for improving cultural responsiveness for GSD populations to increase quit attempts, improve harm reduction implementation related to nicotine consumption, improve primary prevention of smoking, and improve tobacco cessation efforts. Following a 45-minute didactic there will be a 15-minute Q+A to address current questions and concerns related to smoking cessation among GSD populations.
Medical providers, nurses, social workers, Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), recovery coaches, counselors, Licensed Mental health Counselors (LMHC), and members of the community.
Dr. Jamie L. Garfield (she/her) is a Professor of Thoracic Medicine and Surgery at the Temple Lung Center at the Lewis Katz School of Medicine. Dr. Garfield's research, advocacy, and clinical efforts are focused on interventional pulmonology, lung cancer, and tobacco dependence. Dr. Garfield is an LGBTQ affirming provider and a member of the LGBTQ community herself. In her clinical practice, she provides smoking cessation counseling specifically to LGBTQ people and through her research and advocacy work, she strives to improve heath disparities for LGBTQ people, especially those relating to tobacco product use, dependence, and cessation.
Hasmeena Kathuria, MD (she/her)Dr. Kathuria is a pulmonologist at Boston Medical Center and an Associate Professor at Boston University Chobanian & Avedisian School of Medicine Medical School. Her current research, advocacy, and clinical efforts are focused on clinical care and policy surrounding tobacco dependence in underserved populations. Her expertise is in developing and directing patient-centered programs in safety-net settings to improve lung cancer outcomes. She developed and directs the Tobacco Treatment Center at Boston Medical Center, a program that brings together a team of health professionals who specialize in helping people stop smoking. She is Chair of the ATS Tobacco Action Committee, where she collaborates with Government Relations and others with interest in tobacco control policies and serves as the Section Editor to UpToDate, Tobacco Treatment.
Annie Potter, MSN, MPH, NP, CARN-AP (she/her)Annie is a clinical nurse educator for Boston Medical Center's Grayken Center for Addiction Training and Technical Assistance, an assistant professor of medicine at Boston University Chobanian & Avedisian School of Medicine, and a nurse practitioner at Boston Medical Center. Annie contributes to peer-reviewed publications, evidence-based clinical guidelines, development and delivery of continuing education programs, and other resources for clinicians supporting patients with substance use disorders. Annie is also consultant and educator for the Massachusetts HEALing Communities Study, a multi-state study funded by the National Institute on Drug Abuse. She is also the Medical Director for the Massachusetts Community Health Center ECHO and an expert faculty member of the Provider Clinical Support System Exchange (PCSS-X). Annie's other clinical interests include treatment and prevention of HIV and Hepatitis C, family planning, and care for gender-diverse individuals. Before joining Boston Medical Center, Annie practiced at a community health center in Baltimore, MD, where she established and directed the city's first walk-in HIV treatment and prevention program. She is board-certified in addictions and holds specialty certifications for the treatment of HIV and Hepatitis C. Annie earned both her Master of Nursing and Master of Public Health from Johns Hopkins University.
Following this training, participants will have the knowledge necessary to:
Boston Medical Center Grayken Center for Addiction TTA, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS).
Funding for out of state attendees is provided by the Opioid Response Network (ORN).
Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Boston Medical Center grants 1.00 hours to all nurses who attend and complete the evaluation. Boston Medical Center is approved as a provider of nursing continuing professional development by American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
As a Jointly Accredited Organization, Boston University Chobanian & Avedisian School of Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.00 general continuing education credits.
BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs. For this program, 1.00 contact hours will be offered to participants who attend the training and complete the evaluation.
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.